伊人精品一区二区三区_国产AV一区二区三区制服_国产精品黑色丝袜久久

Spearheading Chinese Innovations in CNS Precision Medicine

About Dr. Brain

Shenzhen Yiwei Medical Technology Co., Ltd. is a leader in precise diagnosis and treatment of brain diseases in China, and the first brain science artificial intelligence enterprise to focus on ultra early screening and precise diagnosis and treatment of brain diseases. Yiwei's core products focus on precise screening, diagnosis, and rehabilitation treatment of brain diseases such as Alzheimer's disease and developmental disorders in stroke children. It is the only digital product company in China that covers the entire process of brain disease diagnosis and treatment.

Medical science has now led the industry in completing NMPA, CE, and FDA certifications for multiple brain disease functional modules, especially in the field of AD diagnosis. It has successfully completed the world's first NMPA Class III registration certificate for Alzheimer's disease AI assisted diagnosis in a multicenter clinical trial, won the national high-tech enterprise qualification, and has obtained more than 70 invention patents and software copyrights. The product has been implemented and applied in more than 200 tertiary hospitals and physical examination institutions nationwide, and has engaged in strategic cooperation with multiple top medical institutions, such as Meinian Health, Beilu Pharmaceutical, Baoshi Hua Medical Group, Haier Yingkang, etc; Yiwei has taken the lead in creating a full process diagnosis and treatment platform in China that covers precise diagnosis, disease screening, brain health management, and digital rehabilitation treatment, forming the most clinical and practical closed-loop business model

Core values

Corporate philosophy

Founding team

  • Dr. Silun Wang Co-Founder & CEO

    Dr. Wang was the youngest doctor fighting SARS on the front line at Peking University People's Hospital. He obtained his M. Phil and Ph.D. from the University of Hong Kong, and then completed his postdoctoral research fellowship at the Johns Hopkins University. He is a Junior Fellow of the International Society of Magnetic Resonance in Medicine (ISMRM), and a recipient of a “molecular imaging” research award from the Radiological Society of North America (RSNA). During his two decades dedicated to relevant research, Dr. Wang has published more than 30 papers in SCI-listed journals with over a thousand citations.

  • Mr. Zhaohan Lin Co-Founder, COO & CFO

    Mr. Lin graduated from The Chinese University of Hong Kong and Tsinghua University with a degree in finance, and has served as strategy consultant for world-renowned management consulting firms and as investment and financing director for a Fortune 500 company listed in Hong Kong, in charge of cross-border mergers and acquisitions and overseas listings.

Our aim

Corporate goals

With the whole brain imaging database and deep learning algorithms as the technological cornerstone, the AI-based diagnostic platform as the basis, and the professional, efficient operation services as the means, build Dr. Brain into a world-leading provider of precision diagnosis and treatment solutions for brain diseases.

Our vision

Corporate vision

Create wonders with AI to achieve lifelong brain health